{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:10:22Z","timestamp":1738645822612,"version":"3.35.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,3]]},"DOI":"10.1093\/bjd\/ljae455","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:49:16Z","timestamp":1738576156000},"page":"i1-i2","source":"Crossref","is-referenced-by-count":0,"title":["Hidradenitis suppurativa<i>: BJD<\/i> state-of-the-art review series"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-1142","authenticated-orcid":false,"given":"John R","family":"Ingram","sequence":"first","affiliation":[{"name":"Division of Infection & Immunity, Cardiff University , Cardiff ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"2025020309491076400_ljae455-B1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/bjd.15255","article-title":"NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?","volume":"176","author":"Ingram","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025020309491076400_ljae455-B2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"2025020309491076400_ljae455-B3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025020309491076400_ljae455-B4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamasurg.2021.3655","article-title":"Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa: the SHARPS randomized clinical trial","volume":"156","author":"Bechara","year":"2021","journal-title":"JAMA Surg"},{"key":"2025020309491076400_ljae455-B5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"2025020309491076400_ljae455-B6","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"key":"2025020309491076400_ljae455-B7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025020309491076400_ljae455-B8","article-title":"Interventions for hidradenitis suppurativa","volume":"10","author":"Ingram","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025020309491076400_ljae455-B9","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/bjd\/ljae238","article-title":"Unravelling the complex pathogenesis of hidradenitis suppurativa","volume":"192","author":"Frew","year":"2025","journal-title":"Br J Dermatol"},{"key":"2025020309491076400_ljae455-B10","first-page":"i22","article-title":"Leveraging genotypes and phenotypes to implement precision medicine in hidradenitis suppurativa management","volume":"192","author":"Petukova","year":"2025","journal-title":"Br J Dermatol"},{"key":"2025020309491076400_ljae455-B11","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1093\/bjd\/ljae318","article-title":"An evolutionary tale on clinical trials in hidradenitis suppurativa","volume":"192","author":"Sayed","year":"2025","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/Supplement_1\/i1\/61739054\/ljae455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/Supplement_1\/i1\/61739054\/ljae455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:49:23Z","timestamp":1738576163000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/192\/Supplement_1\/i1\/7997105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":11,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae455","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,2]]}}}